Our Team

Perhaps the greatest challenge in biomedical research is being able to effectively and efficiently translate the knowledge acquired from basic science investigations into viable clinical interventions. Our approach to the “Translational Dilemma” is to harness the power of advanced simulation methods with cutting edge computational tools, such as machine learning and evolutionary computation, while utilizing some of the world’s most powerful high-performance computing platforms. We are a multi-disciplinary team consisting of physicians, physicists, and computational scientists; this span of expertise provides us the range of perspectives to address the complex challenges of turning experimental information into actionable knowledge.

Gary An, MD

Gary An, MD

Professor of Surgery
Principal Investigator

I have more than 25 years of experience with agent-based modeling of inflammation and the immune response, being the first researcher to publish on the use of agent-based modeling in the area of acute inflammation and sepsis. I have partnered with collaborators at the University of Pittsburgh to expand and extend the use of mathematical modeling in the area of sepsis and acute inflammation and wound healing, including the development of one of the first modular multi-organ system ABMs of sepsis. I have been an active participant of the IMAG MSM Consortium since 2011, most recently being an active member of the MSM Working Group on Viral Pandemics and the Subgroup on Developing Immune Digital Twins. I have been active in the agent-based modeling community for more than two decades, having served as the President of the Swarm Development Group from 2008-2015, an organization descended from one of the earliest agent-based modeling toolkits, Swarm, initially developed at the Santa Fe Institute, and am a current executive board member. I am a co-Founder of the Society for Complexity in Acute Illness, a scientific society designed to bring together laboratory scientists, clinical investigators and computational researchers to study systemic inflammation and acute disease. For the past decade I have worked with Chase Cockrell to develop complex agent-based models of various pathophysiological processes, and collaborating and supporting him as he developed several novel methods that integrated agent-based modeling with advanced computational methods such as evolutionary computing/genetic algorithms, machine/active learning and model-based artificial intelligence to identify fundamental insights into the dynamics of systemic inflammation and develop pathways for multi-modal control discovery of sepsis.

Chase Cockrell, PhD

Chase Cockrell, PhD

Associate Professor of Surgical Research
Principal Investigator

I received my PhD in Computational Nuclear Physics, where I had experience in high-performance computing implementations of nuclear physics simulations. My post-doctoral and faculty research has focused on computational biology, including the development of high-resolution tissue realistic agent-based models of the gut and volumetric muscle loss, and the use of simulations to study various aspects of the immune system with a focus on characterizing sepsis, which is a disordered immune response to infection. My most recent work has focused on the use of machine learning techniques to calibrate, validate, and control complex simulation models of cellular and molecular pathophysiology, informed by experimental and clinical data. In my most recent work, I have utilized machine-learning techniques to operate on clinical/electronic health record data, which demonstrate the ability to detect generalizable physiological signatures across populations, predict the onset of long COVID, or identify disease in medical images.

Damien Socia

Damien Socia

Machine Learning Engineer

In my role as a Machine Learning Engineer at the University of Vermont's An-Cockrell Lab, I've been immersed in the world of biological modeling and machine learning research. During my time here, I've gained valuable experience in diverse aspects of this field. Utilizing computer vision to diagnose Trachoma, a tropical eye disease, learning techniques to train ML models on sparse biomedical datasets, and developing agent based models of biological systems. My career is dedicated to the innovative use of technology to solve complex issues in healthcare and research, and I look forward to advancing this mission in my future endeavors.